https://www.selleckchem.com/pr....oducts/Nicotinamide(
lished by Oxford University Press on behalf of Infectious Diseases Society of America.Background Recent studies in gram-negative bacteremia (GN suggest that intravenous (IV) to oral (PO) switch and short treatment durations yield similar clinical outcomes and fewer adverse events. Antimicrobial stewardship program (ASP) bundled initiatives have been associated with improved clinical outcomes for bloodstream infections. Methods This single-center retrospective cohort evaluation included inpatient adults from 11/2014-1
إعجاب
علق
شارك
